Loading current stock analysis…
Loading current stock analysis…
India
As of 18 Sept 2026, 03:30 pm
Colgate-Palmolive (India) Limited officials are scheduled to participate in two investor events in September 2026. On September 11, 2026, the company will attend the UBS India Summit 2026, hosted by UBS in Mumbai. On September 23, 2026, company officials will attend a physical group meeting with J.P. Morgan India's Consumption Forum, also in Mumbai. Both events are described as opportunities to discuss the company's business overview and long-term strategy. The company has stated that no presentations will be made and no unpublished price-sensitive information will be shared during these events.
As of September 18, 2026, Colgate-Palmolive (India) Limited has shown mixed performance across various periods. The stock has seen positive returns over the last 1 month (+1%) and 10 days (+4%). However, it has experienced negative returns over longer durations, including the last 3 months (-5%), year-to-date (-8%), and the last year (-19%). The return since the start of its trading history is -29%.
As of September 18, 2026, daily technical indicators suggest a mixed trend. The closing price was ₹1917.8, with the 20-day Exponential Moving Average (EMA) at ₹1864.86 and the 50-day EMA at ₹1928.39. The Supertrend indicator is 'bullish' at ₹1753.9. However, the monthly trend shows a 'bearish' Supertrend at ₹2595.84, with the 20-day EMA at ₹2192.98. The weekly trend also indicates a 'bearish' Supertrend at ₹2103.24, with the 20-day EMA at ₹1976.95.
As of 18 Sept 2026, 03:30 pm
Showing 3 of 5 candles
Recent drawdown or price variability is materially high and may lead to larger short-term outcomes.
Primary driver: Price remains materially below a previous peak
Upward price movement of 3.16 standard deviations recorded on 2026-09-18.
Unusual market activity that may warrant review of the underlying price, volume, or news context.
Upward price movement of 2.87 standard deviations recorded on 2026-09-18.
Unusual market activity that may warrant review of the underlying price, volume, or news context.
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
The session opened materially below the previous close, indicating a sharp repricing at the open.
The price gap may increase short-term downside uncertainty and warrants review of the underlying context.
Latest complete financial results for Q1 FY2027 and comparative quarterly trends.
| Metric | Q1 FY2026-27(Latest) | Q4 FY2025-26 | Q3 FY2025-26 | Q2 FY2025-26 | Q1 FY2025-26 |
|---|---|---|---|---|---|
| Revenue From Operations | PEAK₹1,603.30 crore | ₹1,595.35 crore | ₹1,486.13 crore | ₹1,519.50 crore | ₹1,434.06 crore |
| Expenses | PEAK₹1,160.57 crore | ₹1,121.61 crore | ₹1,081.32 crore | ₹1,092.25 crore | ₹1,020.05 crore |
| Finance Costs | PEAK₹1.03 crore | ₹81 lakh | ₹97 lakh | ₹99 lakh | ₹1.02 crore |
| Profit Before Tax | ₹462.19 crore | PEAK₹474.03 crore | ₹435.70 crore | ₹442.28 crore | ₹431.95 crore |
| Profit Loss For Period | ₹343.08 crore | PEAK₹353.32 crore | ₹323.86 crore | ₹327.51 crore | ₹320.62 crore |
| Tax Expense | ₹119.11 crore | PEAK₹120.71 crore | ₹111.84 crore | ₹114.77 crore | ₹111.33 crore |
In Q1 FY2026-27, Colgate Palmolive India’s revenue grew 11.8% year-on-year, but a 13.8% rise in total expenses caused profit margins to contract. On a sequential basis, revenue was nearly flat while expenses increased, leading to lower pre-tax and net profit compared to the previous quarter.
Colgate Palmolive India delivered year-on-year revenue growth in Q1 FY2026-27, but expenses increased at a faster pace, squeezing profit margins. Sequentially, revenue was nearly flat while costs rose, resulting in lower pre-tax and net profit. The quarter’s results highlight the impact of rising expenses on profitability despite top-line expansion.
Exchange disclosures and regulatory announcements for Colgate Palmolive (India).
Colgate-Palmolive (India) Limited announced that its officials will attend a physical Group meeting with J.P. Morgan India's Consumption Forum on September 23, 2026, at 9:00 a.m. IST. The company confirmed that no presentation will be made and no unpublished price-sensitive information will be shared during the event. This schedule is subject to change due to unavoidable circumstances.
Colgate Palmolive (India) Limited has scheduled an analyst meet on 2026-09-23 at 09:00 at the St Regis, Mumbai, as part of the J.P. Morgan India Consumption Forum. The in-person group meeting with representatives from J.P. Morgan India will discuss the company's business overview and long-term strategy.
Colgate Palmolive (India) Limited will participate in the UBS India Summit 2026 hosted by UBS on September 11, 2026, at 10:00 AM at Trident, Nariman Point, Mumbai. The in-person group meeting with representatives from UBS India and others will discuss the company's business overview and long-term strategy.
Colgate-Palmolive (India) Limited announced that its officials will attend the UBS India Summit 2026 on Friday, September 11, 2026, at 10:00 a.m. IST in a physical group meeting format. The company confirmed that no presentation will be made and explicitly stated that no unpublished price-sensitive information will be shared during the event. This disclosure was filed with the BSE and NSE on September 7, 2026, by Company Secretary Jaikishan Rohit Shah.
On September 7, 2026, Colgate-Palmolive (India) Limited notified the Bombay Stock Exchange and National Stock Exchange of a newspaper advertisement published in the Free Press Journal regarding the loss of share certificates. The notice was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with copies made available on the company's investor website at www.colgateinvestors.co.in. Jaikishan Shah, the Company Secretary and Compliance Officer, signed the filing to place the matter on record.
Mr. G. Ramprasad resigned as Internal Auditor of Colgate-Palmolive (India) Limited, effective from the close of business on August 31, 2026, to explore opportunities outside the company.
On August 31, 2026, Colgate Palmolive (India) Limited reported the resignation of Mr. G. Ramprasad from the position of Internal Auditor, effective immediately on that date.
On August 21, 2026, the Board of Colgate-Palmolive (India) Limited approved the resignation of Ms. Prabha Narasimhan as Managing Director and CEO effective September 27, 2026, following her promotion to Executive Vice President - Marketing, Asia-Pacific Division. The Board simultaneously appointed Mr. Manish Anandani as the new Managing Director and CEO for a five-year term starting September 28, 2026, subject to shareholder and statutory approvals. Mr. Anandani, who previously served as Managing Director for India and South Asia at Kenvue and rejoined Colgate-Palmolive in 2026 after an earlier tenure ending in 2018, brings 30 years of experience in sales and marketing leadership.
Recent market and company developments associated with Colgate Palmolive (India).
As per provisional closing data, the barometer index, the S&P BSE Sensex jumped 332.63 points or 0.45% to 74,336.45. The Nifty 50 index added 99 points or 0.43% to 23,217.60. In the past two consecutive trading sessions the Sensex and Nifty declined 1.20% and 1.53%, respectively.
Breakout stocks to buy: Sumeet Bagadia recommends five breakout stocks to buy today — Colgate-Palmolive (India), Gmm Pfaudler, Niva Bupa Health Insurance Company, Capillary Technologies India, and Rossell Techsys.
India is becoming a key growth focus for global consumer companies. Rising incomes and expanding retail offer significant untapped market potential. Companies see opportunities to increase consumption and introduce new products. This shift occurs as China's growth moderates and mature markets show less room. India's large population presents a substantial long-term opportunity for expansion.
Colgate-Palmolive is exploring the sale of mass-market personal care brands like Softsoap and Irish Spring to focus on its core portfolio. The potential sales could exceed $1 billion, with Goldman Sachs assisting in the process, as companies adapt to economic pressures.
Colgate, Palmolive, Colgate Goldman Sachs
While Nike will still remain in the broader S&P 500, its removal from the top 100 has sparked a major conversation about the brand's recent struggles.
Nike S&P 100, Nike removed from S&P 100, Nike exits S&P 100, Nike decline, Nike stock, Nike market cap, Nike turnaround, Nike business strategy, John Donahoe Nike, Elliott Hill Nike, Nike direct-to-consumer strategy, Nike wholesale partners, Nike marketing strategy, Nike competition, Hoka vs Nike, On Running vs Nike, Anta Nike competition, Li-Ning Nike competition, Nike news, S&P 100 rebalance, Nike investors, Nike future, Nike business news, sportswear industry, Nike stock performance.
FMCG, fmcg ceo transition, fmcg stocks
Comprehensive Section Breakdown for Colgate Palmolive (India)
Strategic Vision: Manufactures and markets oral and personal care products.
• Established distribution network
• Brand recognition in oral and personal care segments
Revenue from operations reached ₹1,603.30 crore, up 11.8% from ₹1,434.06 crore in the same quarter last year. Compared to the immediately preceding quarter (Q4 FY2025-26), revenue edged up only 0.5% from ₹1,595.35 crore, indicating a near-flat sequential performance.
Total expenses for the quarter were ₹1,160.57 crore, a 13.8% increase from ₹1,020.05 crore a year ago and a 3.5% rise from ₹1,121.61 crore in the prior quarter. In both comparisons, expenses grew faster than revenue. As a result, the expense-to-revenue ratio climbed to 72.4% from 71.1% a year earlier and 70.3% in the previous quarter.
Profit before tax (PBT) stood at ₹462.19 crore, up 7.0% year-on-year from ₹431.95 crore but down 2.5% sequentially from ₹474.03 crore. Net profit (profit for the period) was ₹343.08 crore, also 7.0% higher than the ₹320.62 crore reported a year ago, but 2.9% lower than the ₹353.32 crore in Q4 FY2025-26.
The PBT margin (PBT as a percentage of revenue) narrowed to 28.8% from 30.1% a year ago and 29.7% in the prior quarter. Similarly, the net profit margin fell to 21.4% from 22.4% a year ago and 22.2% in the previous quarter. The margin compression reflects expenses rising faster than revenue.
Basic earnings per share (EPS) was ₹12.61, compared to ₹11.79 in the year-ago quarter and ₹12.99 in the preceding quarter, consistent with the movement in net profit.
Category: Consumer Goods
Manufactures and markets a comprehensive range of oral care products including toothpastes, toothbrushes, toothpowder, oil pulling products, and mouthwashes.
Key Products & Services: Colgate
Category: Consumer Goods
Markets a specialized range of personal care products.
Key Products & Services: Palmolive
Core Thesis: The company aims to build a healthier future for people and the planet through its product development, business practices, and relationships.
• Product Development: Offers a comprehensive range of oral and personal care products under its flagship brands. • Distribution Network: Operates with a wide distribution network established since its beginnings. • Social Responsibility: Engages in initiatives focused on oral health awareness, education, water conservation, and community betterment.